Key Takeaways
1. Timeline for Development: China aims to transition BCI technology from experimental phases to practical applications by 2027 and develop a competitive BCI industry with global leaders by 2030.
2. Integration of Regulators: The plan incorporates regulators early in the BCI development process to accelerate progress, contrasting with the U.S. FDA approach.
3. Innovation Focus: Emphasis on creating advanced implantable electrodes, non-invasive sensors, low-power chips, and real-time decoding software to improve BCI technology.
4. Diverse Applications: BCI technology will be applied in assistive devices, surgical robots, consumer wearables, and industrial uses, enhancing safety and efficiency in various sectors.
5. International Standards and Funding: China plans to set global BCI standards and will support funding through various sources, while inviting foreign research and manufacturing to establish in the country.
China has released an “Implementation Plan for Promoting Innovation and Development of the Brain-Computer Interface (BCI) Industry,” created with input from seven government ministries. This plan shows a unified effort to advance BCI technology. The goal is to transition BCIs from experimental phases to practical clinical applications by 2027, while also nurturing competitive domestic companies by 2030. Unlike the FDA-focused approach in the U.S., China is integrating regulators into the process right from the start to speed things up.
Goals for 2027 and 2030
By 2027, China hopes to achieve significant progress in electrodes, chips, and devices that would enable their use in various sectors, including manufacturing, healthcare, and consumer industries, aiming to establish two to three industrial hubs. By 2030, the country plans to have a secure and dependable BCI industry, featuring a handful of globally significant leaders and a pipeline of specialized small and medium-sized enterprises, all contributing to a competitive ecosystem. To facilitate this, the Central Science and Technology Commission will oversee coordination, encouraging both central and local governments to work together on pilot projects and scaling efforts more effectively.
Focus Areas and Innovations
The plan emphasizes creating implantable electrodes that offer more channels and better body compatibility, along with enhanced materials and clearer signal quality. It also promotes new types of non-invasive electrodes and sensors that utilize alternative signals, such as light or electrical impulses, to extract more detailed information. For computing needs, the strategy promotes the use of low-power implantable chips, real-time decoding software, and mass production of wearable devices. Reports from state media highlight early advancements, including the creation of domestic BCI chips and 128-channel electrodes designed for stable, long-term functionality.
Diverse Applications
The range of applications includes assistive technologies merging brain signals with electromyography, electrooculography, electrocardiography, and near-infrared signals, as well as developing surgical robots that can operate with submicron precision and improved imaging capabilities. Plans also extend to consumer and industrial uses, such as non-invasive wearables aimed at enhancing driver alertness and ensuring workplace safety.
Moreover, Beijing intends to set international standards and promote them globally, while also reinforcing data protection regulations to ensure brain privacy. There will be additional guidelines for registering BCI medical devices. Funding will be drawn from national and small business funds, industry-finance platforms, and insurance options to reduce risks tied to new products. The plan also invites foreign research facilities and manufacturing plants to establish operations in China.
Source:
Link
Leave a Reply